Weight loss management
What the FAA's documents say about weight loss management, in plain words, with the FAA's own words one press away.
FAA term: Weight Loss Management (Use of Medication for Obesity or Overweight)
Short version
The FAA's table sorts it into three rows.
| Situation | What the examiner does | Pathway |
|---|---|---|
| Row ALifestyle changes, or acceptable over-the-counter medicines | Examiner issues | Examiner can issue |
| Row BOne diabetes medicine, not insulin | Worksheet | CACI |
| Row CTwo or more diabetes medicines, not insulin | Defers to the FAA | Special Issuance |
Show the FAA's words: the FAA's table for Weight loss management
- Row A · Examiner can issue
Treated with lifestyle intervention or acceptable over-the-counter (OTC) medications. The table points to the Weight Loss Medications page. It says ISSUE where the examiner can determine the condition is under control, the current medications are acceptable and there are no symptoms that would interfere with flight duties, and has the examiner annotate this information in Block 60.
Treated with lifestyle intervention or acceptable over-the-counter (OTC) medications See Weight Loss Medications If the AME can determine the condition is: Under control; Current medications are acceptable; and The individual has no symptoms that would interfere with flight duties: ISSUE Annotate this information in Block 60.
- Row B · CACI
Treated with one non-insulin diabetic medication component. The table sends the examiner to the CACI worksheet for weight loss management. It requires either a current, detailed progress note from the treating physician and an A1C from no more than 90 days before the exam, or the Weight Loss Management Status Report. If the pilot meets all the worksheet's criteria and is otherwise qualified, the table says ISSUE, and has the examiner annotate the correct CACI statement in Block 60 and keep the required supporting information on file.
Treated with ONE diabetic medication (non-insulin) component See the CACI – Weight Loss Management Worksheet … This requires a current, detailed Clinical Progress Note from the treating physician and Hemoglobin A1c lab performed no more than 90 days before the AME exam. … OR … Weight Loss Management Status Report … If the pilot meets all CACI worksheet criteria and is otherwise qualified: ISSUE Annotate the correct CACI statement in Block 60 and keep the required supporting information on file.
- Row C · Special Issuance
Treated with two or more non-insulin diabetic medication components. The table has the examiner defer and submit either the status report or a current, detailed progress note from the treating physician containing all the required information listed in the status report, to the FAA for a possible Special Issuance, and annotate the elements or findings in Block 60.
Treated with TWO (2) or more diabetic medication (non-insulin) components … Submit either: … Weight Loss Management Status Report … A current, detailed Clinical Progress Note from the treating physician which contains all the required information listed in the above status report. … DEFER Submit the information to the FAA for a possible Special Issuance Annotate (elements or findings) in Block 60.
- A note on the table, 1
In its row for two or more components, the table notes that where the medication is taken for weight loss and the individual has a diagnosis of diabetes, the reader should see the address it prints.
Treated with TWO (2) or more diabetic medication (non-insulin) components … Note: If the medication is taken for weight loss, and the individual has a diagnosis of diabetes, see www.faa.gov/go/diabetic
- A note on the table, 2
The table points polycystic ovarian syndrome to its own page.
Note: For Polycystic Ovarian Syndrome (PCOS), see that page.
The FAA pathways for weight loss management
Which exam
Which one describes yours?
The FAA's table sorts it these ways. Choose yours to see its plan.
Your step-by-step plan
Step 1: Before you begin
Whether you have ever had an A1C of 6.5% or greater, and what your medication is used for.This worksheet is for weight loss management, in a pilot who has never had an A1C of 6.5% or greater.
It is not for
- Not: Anyone who has ever had an A1C of 6.5% or greater
- Not: Diabetes in remission (diet-controlled)
- Not: Diabetes treated with medication, including insulin
- Not: Diabetes insipidus
Show the FAA's words: Before you begin
If the applicant has EVER had an A1C OF 6.5% OR GREATER, DO NOT USE THIS CACI.
FAA source: CACI – Weight Loss Management Worksheet. FAA date 30 September 2026; checked by Crosscheck 14 October 2026.
AME MUST REVIEW ACCEPTABLE CERTIFICATION CRITERIA
Medication is used for:
Note: Diabetes in remission (diet-controlled), diabetes treated with medication (including insulin), or diabetes insipidus DO NOT qualify for this CACI.
[ ] Weight Loss Management
FAA source: CACI – Weight Loss Management Worksheet. FAA date 30 September 2026; checked by Crosscheck 14 October 2026.
Step 2: The progress note, and the A1C or the status report form
The records the examiner reviews, what your treating doctor finds, and the A1C note.Progress note
Within 90 days before the examA current, detailed progress note from a clinic visit with your treating physician or specialist, no more than 90 days before the exam. Your AME reviews it.
What your treating physician finds
- The condition is stable
- No symptoms or complications associated with diabetes
- No side effects from the medication
- No low blood sugar (hypoglycemic events: symptoms, or glucose 70 mg/dL or less) that required intervention in the past 12 months
- Never an A1C of 6.5% or greater
A1C
Within 90 days before the examAn A1C, performed no more than 90 days before the exam.
The result
- Never 6.5% or greater, at any time
- In the prediabetic range, 5.7 to 6.4%, the worksheet points to the prediabetes page
The status report form
The FAA's Weight Loss Management or Prediabetes Status Report, filled in by the provider who prescribes your medication.
The form asks for
- The reason for the medication: weight loss management, or prediabetes or hyperglycemia
- The dates of the last clinical encounter and of the most recent medication change
- The A1C: n/a if the medication is for weight loss only
- Any side effects from medications
- Any low blood sugar episode (hypoglycemia) in the past year
- Whether you take any form of insulin
- Any clinical concerns
- All current medications, for any condition
Once it is filled in
- A narrative, tests and the like attached for any YES answer
- Returned to your AME, to upload into your FAA file
Show the FAA's words: The progress note, and the A1C or the status report form
the AME must review a current, detailed Clinical Progress Note generated from a clinic visit with the treating physician or specialist no more than 90 days prior to the AME exam.
FAA source: CACI – Weight Loss Management Worksheet. FAA date 30 September 2026; checked by Crosscheck 14 October 2026.
Treated with ONE diabetic medication (non-insulin) component
This requires a current, detailed Clinical Progress Note from the treating physician and Hemoglobin A1c lab performed no more than 90 days before the AME exam.
OR
Weight Loss Management Status Report
FAA source: Weight Loss Management Disposition Table. FAA date 27 March 2024; checked by Crosscheck 14 October 2026.
WEIGHT LOSS MANAGEMENT or PREDIABETES STATUS REPORT
Please have the provider who prescribes your medication for weight loss or prediabetes enter the information in the space below.
Return the completed status report to your AME to upload into your FAA file.
Reason for taking this medication:
Prediabetes/hyperglycemia
Weight loss management
Date of last clinical encounter
Date of most recent MEDICATION change
Hemoglobin A1C lab value and date?
A1C required only for prediabetes (dated within 90 days of the AME exam); enter n/a if medication is for weight loss only.
Any side effects from medications?
ANY episode of hypoglycemia in the past year?
Does this patient take ANY form of insulin?
Any clinical concerns?
List ALL current medications (for any condition).
*If any YES answers, please attach narrative, tests, etc.
FAA source: Weight Loss and Prediabetes Status Report. FAA date 29 April 2026; checked by Crosscheck 14 October 2026.
Treating physician finds the condition is stable and NONE of the following are present:
Symptoms or complications associated with diabetes;
Side effects from the medication; Hypoglycemic events (symptoms or glucose 70 mg/dL or less) which required intervention in the past 12 months; and/or
History of A1C 6.5% or greater, ever.
FAA source: CACI – Weight Loss Management Worksheet. FAA date 30 September 2026; checked by Crosscheck 14 October 2026.
Note: If A1c is in the prediabetic range (5.7 to 6.4%), see the Pre-Diabetes page.
FAA source: CACI – Weight Loss Management Worksheet. FAA date 30 September 2026; checked by Crosscheck 14 October 2026.
Step 3: Your medication
The worksheet's medication list, and its observation periods.Only one of the medications the worksheet lists: metformin, liraglutide, orforglipron (Foundayo), semaglutide (Wegovy, by injection or oral) or tirzepatide (Zepbound).
Observation periods
- One week
- 48 hours
Show the FAA's words: Your medication
ONLY ONE of the medications listed is used:
Indicate which one medication is used:
metformin OR
liraglutide OR
orforglipron (Foundayo)
semaglutide* (Wegovy) OR
tirzepatide (Zepbound)
*injection or oral
FAA source: CACI – Weight Loss Management Worksheet. FAA date 30 September 2026; checked by Crosscheck 14 October 2026.
AME should verify one-week observation after starting medication. (See Pharmaceuticals, Weight Loss Medication.) 48-hour observation with each dose increase, medication or formulation change.
FAA source: CACI – Weight Loss Management Worksheet. FAA date 30 September 2026; checked by Crosscheck 14 October 2026.
What the examiner checks
It depends on which row of the FAA's table describes the case.
Row AExaminer issuesExaminer can issue
The table points to the Weight Loss Medications page. It says ISSUE where the examiner can determine the condition is under control, the current medications are acceptable and there are no symptoms that would interfere with flight duties, and has the examiner annotate this information in Block 60.
Row BWorksheetCACI
The table sends the examiner to the CACI worksheet for weight loss management. It requires either a current, detailed progress note from the treating physician and an A1C from no more than 90 days before the exam, or the Weight Loss Management Status Report. If the pilot meets all the worksheet's criteria and is otherwise qualified, the table says ISSUE, and has the examiner annotate the correct CACI statement in Block 60 and keep the required supporting information on file.
Row CDefers to the FAASpecial Issuance
The table has the examiner defer and submit either the status report or a current, detailed progress note from the treating physician containing all the required information listed in the status report, to the FAA for a possible Special Issuance, and annotate the elements or findings in Block 60.
If the examiner defers
Show the FAA's words: what the examiner does on each row
- Row A · Examiner can issue
Treated with lifestyle intervention or acceptable over-the-counter (OTC) medications. The table points to the Weight Loss Medications page. It says ISSUE where the examiner can determine the condition is under control, the current medications are acceptable and there are no symptoms that would interfere with flight duties, and has the examiner annotate this information in Block 60.
Treated with lifestyle intervention or acceptable over-the-counter (OTC) medications See Weight Loss Medications If the AME can determine the condition is: Under control; Current medications are acceptable; and The individual has no symptoms that would interfere with flight duties: ISSUE Annotate this information in Block 60.
- Row B · CACI
Treated with one non-insulin diabetic medication component. The table sends the examiner to the CACI worksheet for weight loss management. It requires either a current, detailed progress note from the treating physician and an A1C from no more than 90 days before the exam, or the Weight Loss Management Status Report. If the pilot meets all the worksheet's criteria and is otherwise qualified, the table says ISSUE, and has the examiner annotate the correct CACI statement in Block 60 and keep the required supporting information on file.
Treated with ONE diabetic medication (non-insulin) component See the CACI – Weight Loss Management Worksheet … This requires a current, detailed Clinical Progress Note from the treating physician and Hemoglobin A1c lab performed no more than 90 days before the AME exam. … OR … Weight Loss Management Status Report … If the pilot meets all CACI worksheet criteria and is otherwise qualified: ISSUE Annotate the correct CACI statement in Block 60 and keep the required supporting information on file.
- Row C · Special Issuance
Treated with two or more non-insulin diabetic medication components. The table has the examiner defer and submit either the status report or a current, detailed progress note from the treating physician containing all the required information listed in the status report, to the FAA for a possible Special Issuance, and annotate the elements or findings in Block 60.
Treated with TWO (2) or more diabetic medication (non-insulin) components … Submit either: … Weight Loss Management Status Report … A current, detailed Clinical Progress Note from the treating physician which contains all the required information listed in the above status report. … DEFER Submit the information to the FAA for a possible Special Issuance Annotate (elements or findings) in Block 60.
The CACI worksheet's criteria
Before you begin
- Not: Anyone who has ever had an A1C of 6.5% or greater
- Not: Diabetes in remission (diet-controlled)
- Not: Diabetes treated with medication, including insulin
- Not: Diabetes insipidus
Progress note
- The condition is stable
- No symptoms or complications associated with diabetes
- No side effects from the medication
- No low blood sugar (hypoglycemic events: symptoms, or glucose 70 mg/dL or less) that required intervention in the past 12 months
- Never an A1C of 6.5% or greater
A1C
- Never 6.5% or greater, at any time
- In the prediabetic range, 5.7 to 6.4%, the worksheet points to the prediabetes page
Your weight loss medication
- One weekAfter starting the medication
- 48 hoursWith each dose increase, medication or formulation change
Show the FAA's words: the CACI worksheet's criteria for Weight loss management
- Never an A1C of 6.5% or greater
The worksheet says that if the applicant has ever had an A1C of 6.5% or greater, do not use this CACI.
If the applicant has EVER had an A1C OF 6.5% OR GREATER, DO NOT USE THIS CACI.
- The medication is being used for weight loss management
The worksheet's acceptable answer for what the medication is used for is weight loss management. Its note says diabetes in remission (diet-controlled), diabetes treated with medication (including insulin), or diabetes insipidus do not qualify for this CACI.
AME MUST REVIEW ACCEPTABLE CERTIFICATION CRITERIA … Medication is used for: … Note: Diabetes in remission (diet-controlled), diabetes treated with medication (including insulin), or diabetes insipidus DO NOT qualify for this CACI. … [ ] Weight Loss Management
- Stable, with none of the worksheet's listed findings present
FAA criterion: the treating physician finds the condition stable and none of the worksheet's listed findings are present. Those are symptoms or complications associated with diabetes; side effects from the medication; hypoglycemic events (symptoms or glucose 70 mg/dL or less) which required intervention in the past 12 months; and/or a history of an A1C of 6.5% or greater, ever.
Treating physician finds the condition is stable and NONE of the following are present: … Symptoms or complications associated with diabetes; … Side effects from the medication; Hypoglycemic events (symptoms or glucose 70 mg/dL or less) which required intervention in the past 12 months; and/or … History of A1C 6.5% or greater, ever.
- If the A1C is in the prediabetic range
The worksheet's note says that if the A1C is in the prediabetic range (5.7 to 6.4%), see the Pre-Diabetes page.
Note: If A1c is in the prediabetic range (5.7 to 6.4%), see the Pre-Diabetes page.
- An observation period after starting the medication, and with each dose increase, medication or formulation change
The worksheet says the examiner should verify a one-week observation after starting the medication, and lists a 48-hour observation with each dose increase, medication or formulation change.
AME should verify one-week observation after starting medication. (See Pharmaceuticals, Weight Loss Medication.) 48-hour observation with each dose increase, medication or formulation change.
If the examiner defersSpecial Issuance
The table marks DEFER where the condition is treated with two or more non-insulin diabetic medication components.
What the FAA lists to send
- Item 1. Either the Weight Loss Management Status Report, where the treating physician must clearly indicate the reason for the medication and whether there is any history of diabetes.
- Item 2. Or a current, detailed clinical progress note from the treating physician which contains all the required information listed in the status report. It must include the indication for the medication and whether there is any history of diabetes, and, under it, the table lists an A1C performed no more than 90 days before the exam.
Show the FAA's words: if the examiner defers
When the examiner defers
- Reason 1
The table marks DEFER where the condition is treated with two or more non-insulin diabetic medication components.
Treated with TWO (2) or more diabetic medication (non-insulin) components … DEFER Submit the information to the FAA for a possible Special Issuance
What the FAA lists to send
- Item 1
Either the Weight Loss Management Status Report, where the treating physician must clearly indicate the reason for the medication and whether there is any history of diabetes.
Submit either: … Weight Loss Management Status Report … (The treating physician must clearly indicate the reason for the medication and if there is any history of diabetes.)
- Item 2
Or a current, detailed clinical progress note from the treating physician which contains all the required information listed in the status report. It must include the indication for the medication and whether there is any history of diabetes, and, under it, the table lists an A1C performed no more than 90 days before the exam.
A current, detailed Clinical Progress Note from the treating physician which contains all the required information listed in the above status report. … It must include the indication for the medication and if there is any history of diabetes or not; … Hemoglobin A1c lab performed no more than 90 days before the AME exam.
What a Special Issuance is
The Guide says an Authorization for Special Issuance, valid for a specified period, may be granted at the Federal Air Surgeon's discretion to a person who does not meet the established medical standards, if the person shows to the satisfaction of the Federal Air Surgeon that the duties authorized by the class of certificate applied for can be performed without endangering public safety during the period the Authorization would be in force.
How the FAA pathways workAt later examsAASI
- First and second class
- Every year
- Third class
- At each required exam
The worksheet says first- and second-class applicants must provide this information every year, and third-class applicants must provide it with each required exam.
Show the FAA's words: how often the FAA asks again
Applicants for first- or second-class must provide this information annually; applicants for third-class must provide the information with each required exam.
Under an Authorization, the AASI page lists what the pilot brings for the examiner to reissue: the Authorization itself and a current, detailed progress note from no more than 90 days before the exam, verifying no interim development of diabetes and/or no low blood sugar requiring intervention or significant side effects, together with an A1C of 6.4 or less from no more than 90 days before recertification.
Show the FAA's words: at later exams
AMEs may re-issue an airman medical certificate under the provisions of an Authorization, if the applicant provides the following: An Authorization granted by the FAA; and … A current, detailed clinical progress note performed no more than 90 days before the AME exam verifying: No interim development of diabetes; and/or … No hypoglycemia requiring intervention or significant side effects … Hemoglobin A1C is 6.4 or less (no more than 90 days before recertification)
What AASI is
AASI stands for AME Assisted Special Issuance. The Guide describes it as a process that lets the examiner reissue a certificate under the provisions of an Authorization for Special Issuance, to an applicant who has a medical condition that is disqualifying under 14 CFR part 67.
How the FAA pathways workThe Authorization granted by the FAA
The AASI page's list for a reissue includes the Authorization the FAA granted.
Show the FAA's words: The Authorization granted by the FAA
AMEs may re-issue an airman medical certificate under the provisions of an Authorization, if the applicant provides the following: … An Authorization granted by the FAA; and
A current, detailed progress note
For a reissue the AASI page asks for a current, detailed progress note from no more than 90 days before the exam, verifying no interim development of diabetes and/or no low blood sugar requiring intervention or significant side effects.
Show the FAA's words: A current, detailed progress note
AMEs may re-issue an airman medical certificate under the provisions of an Authorization, if the applicant provides the following: … A current, detailed clinical progress note performed no more than 90 days before the AME exam verifying: … No interim development of diabetes; and/or … No hypoglycemia requiring intervention or significant side effects
An A1C of 6.4 or less
The AASI page asks for an A1C of 6.4 or less from no more than 90 days before recertification.
Show the FAA's words: An A1C of 6.4 or less
Hemoglobin A1C is 6.4 or less (no more than 90 days before recertification)
What the Authorization letter comes with
The AASI page says the Authorization letter comes with attachments that specify the information the treating doctors must provide for the reissue determination.
Show the FAA's words: What the Authorization letter comes with
The Authorization letter is accompanied by attachments that specify the information that treating physician(s) must provide for the re-issuance determination.
When the examiner defers a reissue
The AASI page says the examiner must defer to the AMCD or Region if additional diabetes medications are added, if diabetes develops, and/or for any other reason for not renewing an AASI.
Show the FAA's words: When the examiner defers a reissue
The AME must defer to the AMCD or Region if: Additional diabetes medications are added; Development of diabetes; and/or Any other reason for not renewing an AASI
Good to know
Points from the FAA's own documents that are easy to miss.
The CACI covers diabetic medication
The worksheet notes that the CACI was expanded to include diabetic medication taken for weight loss.
Show the FAA's words: good to know, 1
NOTE: CACI expanded to include diabetic medication taken for weight loss.
The form's one GLP-1 instruction
Where the pilot takes a GLP-1, the form tells the prescriber to verify there are no psychiatric side effects. The weight loss worksheet also names orforglipron (Foundayo), which the FAA's weight-loss medication page does not list under GLP-1 agonist.
Show the FAA's words: good to know, 2
Please have the provider who prescribes your medication for weight loss or prediabetes enter the information in the space below. … (If taking GLP-1, verify no psychiatric side effects.)
GLP-1 agonist … liraglutide … semaglutide (Wegovy) [injection or oral] … tirzepatide (Zepbound) [GIP + GLP-1 Agonist]
liraglutide OR … orforglipron (Foundayo) … semaglutide* (Wegovy) OR … tirzepatide (Zepbound)
The form points two pilots elsewhere
The form ends with a note. A pilot diagnosed with diabetes is sent to the FAA's diabetes address, and one taking insulin to the FAA's ITDM address.
Show the FAA's words: good to know, 3
Note: If diagnosed with diabetes, see www.faa.gov/go/diabetic. … If taking insulin, see www.faa.gov/go/ITDM.
What a progress note must include
In most cases it should come from a visit with the treating physician no more than 90 days ago, and cover the history, medications with dosages and side effects, exam findings, test results, diagnosis, assessment and plan, prognosis and follow-up. The FAA's sheet says to make sure the physician adds the prognosis. A portal note or an After Visit Summary that does not meet these criteria is not enough, and neither is a simple "ok to fly" letter. The FAA's documents also call it a status report.
Show the FAA's words: good to know, 4
your patient portal to print out “notes” or an “After Visit Summary (AVS).” … Patient Portal notes or an AVS that do not meet the criteria listed below for a detailed Clinical Progress Note are NOT sufficient for FAA purposes. … To be “current,” in MOST CASES, the detailed Clinical Progress Note should be from an evaluation in which you saw your treating physician no more than 90 days ago. … It Must include the following items: … A summary of the history of the condition, … Current medications, dosages, and side effects (if any); … Clinical exam findings; … Results of any testing performed; … Diagnosis; … Assessment and Plan; … Prognosis (This item may not be on a standard progress note, make sure your physician adds this information.); and … Follow-up … Please note: A letter stating, “Mr. Smith is ok to fly” (or any other simple note), is NOT a current, detailed Clinical Progress Note and is NOT acceptable. … You may also see this called a “current status report” or “status report” in current FAA Guidance. Any reference to a “status report” equals the criteria listed on this sheet.
The worksheet says ever twice
The worksheet says ever twice: in its list of findings, and in its line above the criteria, which says that if the applicant has ever had an A1C of 6.5% or greater, do not use this CACI.
Show the FAA's words: good to know, 5
History of A1C 6.5% or greater, ever. … If the applicant has EVER had an A1C OF 6.5% OR GREATER, DO NOT USE THIS CACI.
Brand names beside three medications
The worksheet names the brand beside three of the five medications, and marks one of them as either injection or oral.
Show the FAA's words: good to know, 6
Indicate which one medication is used: … metformin OR … liraglutide OR … orforglipron (Foundayo) … semaglutide* (Wegovy) OR … tirzepatide (Zepbound) … *injection or oral
48-hour observation after each change
The worksheet lists a 48-hour observation with each dose increase, medication or formulation change.
Show the FAA's words: good to know, 7
48-hour observation with each dose increase, medication or formulation change.
A first-time AASI is deferred
For a first-time application for this AASI, where the applicant has all the requisite medical information for a determination, the examiner must defer and submit all of the documentation to the AMCD or RFS for the initial determination.
Show the FAA's words: good to know, 8
If this is a first-time application for an AASI for the above disease/condition, and the applicant has all the requisite medical information necessary for a determination, the AME must defer and submit all of the documentation to the AMCD or RFS for the initial determination.
Two addresses for diabetes
The AASI page sends a pilot diagnosed with diabetes and taking medication other than insulin to one address it prints, and a pilot diagnosed with diabetes and taking insulin to another.
Show the FAA's words: good to know, 9
If diagnosed with diabetes and taking medication other than insulin see: www.faa.gov/go/diabetic … If diagnosed with diabetes and taking insulin see: www.faa.gov/go/itdm
FAA sources
Every FAA document this page relies on, with the FAA's own date and the date Crosscheck last read it. The documents to print open at the FAA, so they are always the FAA's current ones.
- Open to print: CACI – Weight Loss Management Worksheet, a PDF at the FAA, in a new tab
- Weight Loss Management Disposition TableOpen to print: Weight Loss Management Disposition Table, a PDF at the FAA, in a new tab
Examiner can issue, Special Issuance
- AASI for Prediabetes or Overweight/Obesity Treated with MedicationOpen to print: AASI for Prediabetes or Overweight/Obesity Treated with Medication, a PDF at the FAA, in a new tab
The sheet the examiner follows to reissue under an FAA Authorization.
AASI
- Open at the FAA: Weight Loss Medications, a PDF at the FAA, in a new tab
- Open at the FAA: Pilot Information – What a Detailed Clinical Progress Note must contain, a PDF at the FAA, in a new tab
- Open at the FAA: Weight Loss and Prediabetes Status Report, a PDF at the FAA, in a new tab
Related conditions
Each has its own page, with what the FAA's documents say about it.
This reports what the FAA has published. It is not medical advice, and it does not say how the FAA or an examiner will decide a case.